CD163 and colorectal carcinoma: Considering the numbers of cells among the three TIIC subpopulations: CD66b+ TANs, FoxP3+ Tregs, and CD163+ TAMs, and based on ssGSEA and CIBERSORT tools, a new model of prognosis was created for use in effective prognostic evaluation of CRC patients [79].